STOCK TITAN

Hyperfine, Inc. - $HYPR STOCK NEWS

Welcome to our dedicated page for Hyperfine news (Ticker: $HYPR), a resource for investors and traders seeking the latest updates and insights on Hyperfine stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Hyperfine's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Hyperfine's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.4%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.19%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.23%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.73%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.33%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.8%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.72%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.15%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.49%
Tags
conferences
Hyperfine, Inc.

NYSE:HYPR

HYPR Rankings

HYPR Stock Data

64.81M
51.21M
11.94%
26.6%
1.79%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
United States of America
GUILFORD

About HYPR

hyperfine’s mission is to make mri accessible to every patient, regardless of income or resources. anytime. anywhere.hyperfine’s swoop® portable mr imaging system™ addresses limitations of current imaging technologies. swoop wheels directly to a patient’s bedside, where it plugs into a standard electrical outlet and uses an apple ipad® for control. images display within minutes, enabling critical decision-making capabilities across various clinical settings such as neurointensive care units, emergency departments, pediatrics, and more. designed as a complementary system to fixed conventional mri systems, new users can be trained on system operation, device navigation, and safety in about 30 minutes, helping clinicians streamline workflow. the complete swoop™ portable mr imaging system costs less than the annual service contract for most fixed conventional mri systems.in august 2020, swoop received market-ready fda clearance for portable mr imaging of the brain and head for patients of